vs
Enact Holdings, Inc.（ACT）与GE医疗（CCRN）财务数据对比。点击上方公司名可切换其他公司
Enact Holdings, Inc.的季度营收约是GE医疗的1.3倍（$312.7M vs $236.8M），Enact Holdings, Inc.同比增速更快（3.6% vs -23.6%），过去两年Enact Holdings, Inc.的营收复合增速更高（3.6% vs -21.0%）
Enact Holdings, Inc.是美国领先的私人抵押贷款保险服务商，为银行、信用社等各类住宅抵押贷款机构提供风险缓释解决方案，帮助首付较低的购房者获得可负担的住房贷款，助力更多美国普通消费者实现安居需求。
GE医疗是总部位于美国伊利诺伊州芝加哥的医疗科技企业，品牌标识为GE HealthCare。公司主要业务分为四大板块：包含分子影像、CT、磁共振、妇科筛查及X光设备的医学影像业务、超声业务，以及聚焦远程患者监测、麻醉呼吸护理、心脏诊断、婴幼儿护理的患者护理解决方案业务，此外还开展医药相关业务。
ACT vs CCRN — 直观对比
营收规模更大
ACT
是对方的1.3倍
$236.8M
营收增速更快
ACT
高出27.2%
-23.6%
两年增速更快
ACT
近两年复合增速
-21.0%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $312.7M | $236.8M |
| 净利润 | — | $-82.9M |
| 毛利率 | — | — |
| 营业利润率 | 71.3% | -30.2% |
| 净利率 | — | -35.0% |
| 营收同比 | 3.6% | -23.6% |
| 净利润同比 | — | -2109.7% |
| 每股收益（稀释后） | $1.23 | $-2.56 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ACTCCRN
| Q4 25 | $312.7M | $236.8M | ||
| Q3 25 | $311.5M | $250.1M | ||
| Q2 25 | $304.9M | $274.1M | ||
| Q1 25 | $306.8M | $293.4M | ||
| Q4 24 | $301.8M | $309.9M | ||
| Q3 24 | $309.6M | $315.1M | ||
| Q2 24 | $298.8M | $339.8M | ||
| Q1 24 | $291.6M | $379.2M |
净利润ACTCCRN
| Q4 25 | — | $-82.9M | ||
| Q3 25 | — | $-4.8M | ||
| Q2 25 | — | $-6.7M | ||
| Q1 25 | — | $-490.0K | ||
| Q4 24 | — | $-3.8M | ||
| Q3 24 | — | $2.6M | ||
| Q2 24 | — | $-16.1M | ||
| Q1 24 | — | $2.7M |
毛利率ACTCCRN
| Q4 25 | — | — | ||
| Q3 25 | — | 20.4% | ||
| Q2 25 | — | 20.4% | ||
| Q1 25 | — | 20.0% | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 20.4% | ||
| Q2 24 | — | 20.8% | ||
| Q1 24 | — | 20.4% |
营业利润率ACTCCRN
| Q4 25 | 71.3% | -30.2% | ||
| Q3 25 | 67.4% | -2.4% | ||
| Q2 25 | 70.4% | -2.1% | ||
| Q1 25 | 68.9% | -0.3% | ||
| Q4 24 | 68.9% | -1.1% | ||
| Q3 24 | 74.1% | 0.9% | ||
| Q2 24 | 78.6% | -5.7% | ||
| Q1 24 | 70.6% | 0.8% |
净利率ACTCCRN
| Q4 25 | — | -35.0% | ||
| Q3 25 | — | -1.9% | ||
| Q2 25 | — | -2.4% | ||
| Q1 25 | — | -0.2% | ||
| Q4 24 | — | -1.2% | ||
| Q3 24 | — | 0.8% | ||
| Q2 24 | — | -4.7% | ||
| Q1 24 | — | 0.7% |
每股收益（稀释后）ACTCCRN
| Q4 25 | $1.23 | $-2.56 | ||
| Q3 25 | $1.10 | $-0.15 | ||
| Q2 25 | $1.11 | $-0.20 | ||
| Q1 25 | $1.08 | $-0.02 | ||
| Q4 24 | $1.05 | $-0.13 | ||
| Q3 24 | $1.15 | $0.08 | ||
| Q2 24 | $1.16 | $-0.47 | ||
| Q1 24 | $1.01 | $0.08 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $582.5M | $108.7M |
| 总债务越低越好 | $744.5M | — |
| 股东权益账面价值 | $5.4B | $322.8M |
| 总资产 | $6.9B | $449.0M |
| 负债/权益比越低杠杆越低 | 0.14× | — |
8季度趋势，按日历期对齐
现金及短期投资ACTCCRN
| Q4 25 | $582.5M | $108.7M | ||
| Q3 25 | $545.6M | $99.1M | ||
| Q2 25 | $616.0M | $81.2M | ||
| Q1 25 | $639.0M | $80.7M | ||
| Q4 24 | $602.8M | $81.6M | ||
| Q3 24 | $674.9M | $64.0M | ||
| Q2 24 | $711.3M | $69.6M | ||
| Q1 24 | $624.3M | $5.2M |
总债务ACTCCRN
| Q4 25 | $744.5M | — | ||
| Q3 25 | $744.1M | — | ||
| Q2 25 | $743.8M | — | ||
| Q1 25 | $743.4M | — | ||
| Q4 24 | $743.0M | — | ||
| Q3 24 | $742.7M | — | ||
| Q2 24 | $742.4M | — | ||
| Q1 24 | $746.1M | — |
股东权益ACTCCRN
| Q4 25 | $5.4B | $322.8M | ||
| Q3 25 | $5.3B | $408.1M | ||
| Q2 25 | $5.2B | $412.2M | ||
| Q1 25 | $5.1B | $418.2M | ||
| Q4 24 | $5.0B | $419.0M | ||
| Q3 24 | $5.0B | $424.7M | ||
| Q2 24 | $4.8B | $433.3M | ||
| Q1 24 | $4.7B | $462.4M |
总资产ACTCCRN
| Q4 25 | $6.9B | $449.0M | ||
| Q3 25 | $6.9B | $538.2M | ||
| Q2 25 | $6.8B | $553.8M | ||
| Q1 25 | $6.7B | $576.2M | ||
| Q4 24 | $6.5B | $589.3M | ||
| Q3 24 | $6.6B | $597.4M | ||
| Q2 24 | $6.3B | $602.9M | ||
| Q1 24 | $6.3B | $648.4M |
负债/权益比ACTCCRN
| Q4 25 | 0.14× | — | ||
| Q3 25 | 0.14× | — | ||
| Q2 25 | 0.14× | — | ||
| Q1 25 | 0.15× | — | ||
| Q4 24 | 0.15× | — | ||
| Q3 24 | 0.15× | — | ||
| Q2 24 | 0.15× | — | ||
| Q1 24 | 0.16× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $724.5M | $18.2M |
| 自由现金流经营现金流 - 资本支出 | — | $16.1M |
| 自由现金流率自由现金流/营收 | — | 6.8% |
| 资本支出强度资本支出/营收 | — | 0.9% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | — | $40.1M |
8季度趋势，按日历期对齐
经营现金流ACTCCRN
| Q4 25 | $724.5M | $18.2M | ||
| Q3 25 | $192.0M | $20.1M | ||
| Q2 25 | $119.5M | $4.2M | ||
| Q1 25 | $226.7M | $5.7M | ||
| Q4 24 | $686.3M | $24.2M | ||
| Q3 24 | $188.1M | $7.5M | ||
| Q2 24 | $144.7M | $82.4M | ||
| Q1 24 | $187.3M | $6.0M |
自由现金流ACTCCRN
| Q4 25 | — | $16.1M | ||
| Q3 25 | — | $17.9M | ||
| Q2 25 | — | $2.3M | ||
| Q1 25 | — | $3.8M | ||
| Q4 24 | — | $21.7M | ||
| Q3 24 | — | $6.3M | ||
| Q2 24 | — | $79.6M | ||
| Q1 24 | — | $3.8M |
自由现金流率ACTCCRN
| Q4 25 | — | 6.8% | ||
| Q3 25 | — | 7.2% | ||
| Q2 25 | — | 0.8% | ||
| Q1 25 | — | 1.3% | ||
| Q4 24 | — | 7.0% | ||
| Q3 24 | — | 2.0% | ||
| Q2 24 | — | 23.4% | ||
| Q1 24 | — | 1.0% |
资本支出强度ACTCCRN
| Q4 25 | — | 0.9% | ||
| Q3 25 | — | 0.9% | ||
| Q2 25 | — | 0.7% | ||
| Q1 25 | — | 0.6% | ||
| Q4 24 | — | 0.8% | ||
| Q3 24 | — | 0.4% | ||
| Q2 24 | — | 0.8% | ||
| Q1 24 | — | 0.6% |
现金转化率ACTCCRN
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 2.92× | ||
| Q2 24 | — | — | ||
| Q1 24 | — | 2.23× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
ACT
暂无分部数据
CCRN
| Temporary Staffing Services | $189.6M | 80% |
| Physician Staffing | $42.5M | 18% |
| Other Services | $4.7M | 2% |
